Neurology Live

The professor of cognitive neuroscience and imaging at the University of Western Ontario, Canada, detailed new research using the Creyos platform and machine learning to develop a rapid, scalable cognitive screener designed to identify early signs of cognitive decline and dementia risk. Early identification of cognitive changes has become increasingly important as emerging disease-modifying therapies and supportive technological interventions may offer the greatest benefit when implemented during the earliest stages of impairment.
See full story at Neurology Live
Sign up for our newsletter!
Get the latest information and inspirational stories for caregivers, delivered directly to your inbox.